Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 7 studies | 22% ± 6% | |
epithelial cell | 6 studies | 32% ± 13% | |
squamous epithelial cell | 4 studies | 33% ± 19% | |
Mueller cell | 4 studies | 22% ± 3% | |
goblet cell | 4 studies | 32% ± 18% | |
GABAergic neuron | 3 studies | 43% ± 6% | |
glutamatergic neuron | 3 studies | 48% ± 7% | |
basal cell | 3 studies | 33% ± 13% | |
transit amplifying cell | 3 studies | 33% ± 23% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 4 studies | 31% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 558.47 | 180 / 180 | 100% | 14.06 | 430 / 430 |
bladder | 100% | 1040.62 | 21 / 21 | 100% | 15.79 | 503 / 504 |
intestine | 100% | 923.22 | 965 / 966 | 99% | 13.27 | 522 / 527 |
uterus | 100% | 689.89 | 170 / 170 | 98% | 19.52 | 452 / 459 |
stomach | 98% | 887.16 | 352 / 359 | 100% | 12.70 | 285 / 286 |
pancreas | 99% | 579.94 | 325 / 328 | 98% | 12.56 | 175 / 178 |
breast | 99% | 696.62 | 456 / 459 | 98% | 13.34 | 1094 / 1118 |
thymus | 100% | 838.57 | 653 / 653 | 97% | 7.29 | 586 / 605 |
kidney | 100% | 747.27 | 89 / 89 | 97% | 8.80 | 872 / 901 |
esophagus | 97% | 1757.16 | 1405 / 1445 | 99% | 16.20 | 182 / 183 |
lung | 97% | 556.66 | 559 / 578 | 99% | 13.36 | 1145 / 1155 |
prostate | 100% | 848.06 | 245 / 245 | 93% | 7.56 | 465 / 502 |
adrenal gland | 98% | 544.76 | 254 / 258 | 90% | 9.04 | 207 / 230 |
skin | 100% | 1476.55 | 1809 / 1809 | 77% | 5.50 | 363 / 472 |
brain | 96% | 618.10 | 2548 / 2642 | 77% | 4.33 | 541 / 705 |
lymph node | 0% | 0 | 0 / 0 | 100% | 8.80 | 29 / 29 |
spleen | 100% | 747.44 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 15.28 | 45 / 45 |
adipose | 100% | 586.50 | 1199 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 94% | 396.80 | 1256 / 1335 | 0% | 0 | 0 / 0 |
heart | 92% | 511.41 | 795 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 619.77 | 727 / 929 | 0% | 0 | 0 / 0 |
liver | 19% | 46.75 | 43 / 226 | 25% | 1.93 | 101 / 406 |
eye | 0% | 0 | 0 / 0 | 29% | 1.23 | 23 / 80 |
muscle | 22% | 60.95 | 176 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0018345 | Biological process | protein palmitoylation |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_1903830 | Biological process | magnesium ion transmembrane transport |
GO_0030660 | Cellular component | Golgi-associated vesicle membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0016020 | Cellular component | membrane |
GO_0016409 | Molecular function | palmitoyltransferase activity |
GO_0019706 | Molecular function | protein-cysteine S-palmitoyltransferase activity |
GO_0015095 | Molecular function | magnesium ion transmembrane transporter activity |
Gene name | ZDHHC13 |
Protein name | Palmitoyltransferase ZDHHC13 (EC 2.3.1.225) (Huntingtin-interacting protein 14-related protein) (HIP14-related protein) (Huntingtin-interacting protein HIP3RP) (Putative MAPK-activating protein PM03) (Putative NF-kappa-B-activating protein 209) (Zinc finger DHHC domain-containing protein 13) (DHHC-13) |
Synonyms | HIP14L HIP3RP |
Description | FUNCTION: Palmitoyltransferase that could catalyze the addition of palmitate onto various protein substrates (By similarity). Palmitoyltransferase for HTT and GAD2. May play a role in Mg(2+) transport. . |
Accessions | ENST00000446113.7 [Q8IUH4-1] Q8IUH4 ENST00000399351.7 [Q8IUH4-3] |